Glutamate Receptor 1 antibody (pThr856) (FITC)
Quick Overview for Glutamate Receptor 1 antibody (pThr856) (FITC) (ABIN1709958)
Target
See all Glutamate Receptor 1 (GLUR1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pThr856
-
Cross-Reactivity
- Rat
-
Predicted Reactivity
- Human,Mouse,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic phosphopeptide derived from human Glutamate Receptor 1 around the phosphorylation site of Thr856
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- Glutamate Receptor 1 (GLUR1)
-
Alternative Name
- GluR1
-
Background
-
Synonyms: Glutamate receptor 1, GluR-1, AMPA-selective glutamate receptor 1, GluR-A, GluR-K1, Glutamate receptor ionotropic, AMPA 1, GluA1, GRIA1, GLUH1, GLUR1
Background: Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.
-
Gene ID
- 2890
-
Pathways
- PI3K-Akt Signaling
Target
-